IRIS
SARMATI, LOREDANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 58.756
AS - Asia 9.755
EU - Europa 8.007
SA - Sud America 1.495
AF - Africa 204
OC - Oceania 103
Continente sconosciuto - Info sul continente non disponibili 26
Totale 78.346
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 58.445
SG - Singapore 4.467
IT - Italia 1.752
CN - Cina 1.745
BR - Brasile 1.221
RU - Federazione Russa 1.177
DE - Germania 1.061
HK - Hong Kong 957
VN - Vietnam 792
IE - Irlanda 713
UA - Ucraina 713
KR - Corea 673
FR - Francia 470
GB - Regno Unito 465
SE - Svezia 427
FI - Finlandia 396
JP - Giappone 279
IN - India 223
PL - Polonia 212
CA - Canada 174
NL - Olanda 152
ES - Italia 111
BD - Bangladesh 96
AU - Australia 94
AR - Argentina 93
AT - Austria 89
MX - Messico 88
ID - Indonesia 82
TR - Turchia 79
BE - Belgio 76
ZA - Sudafrica 72
IQ - Iraq 68
CZ - Repubblica Ceca 51
PK - Pakistan 45
CO - Colombia 44
EC - Ecuador 35
CL - Cile 33
PH - Filippine 33
MA - Marocco 25
VE - Venezuela 25
LT - Lituania 24
SA - Arabia Saudita 21
CH - Svizzera 20
KG - Kirghizistan 20
PY - Paraguay 20
TN - Tunisia 19
UZ - Uzbekistan 19
JO - Giordania 18
KE - Kenya 18
AE - Emirati Arabi Uniti 17
IL - Israele 17
EG - Egitto 16
RO - Romania 16
TW - Taiwan 16
EU - Europa 14
IR - Iran 13
KZ - Kazakistan 13
DZ - Algeria 12
GR - Grecia 12
JM - Giamaica 11
PE - Perù 11
HN - Honduras 9
NZ - Nuova Zelanda 9
PT - Portogallo 9
BH - Bahrain 8
DO - Repubblica Dominicana 8
NP - Nepal 8
UY - Uruguay 8
ET - Etiopia 7
TH - Thailandia 7
AL - Albania 6
AZ - Azerbaigian 6
LB - Libano 6
LV - Lettonia 6
NG - Nigeria 6
NO - Norvegia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
HR - Croazia 5
MY - Malesia 5
SC - Seychelles 5
XK - ???statistics.table.value.countryCode.XK??? 5
MD - Moldavia 4
PA - Panama 4
RS - Serbia 4
SI - Slovenia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
CM - Camerun 3
CR - Costa Rica 3
DK - Danimarca 3
GA - Gabon 3
KH - Cambogia 3
MK - Macedonia 3
MN - Mongolia 3
OM - Oman 3
PS - Palestinian Territory 3
Totale 78.303
Salva come PNG Salva come JPEG
Città #
Woodbridge 14.891
Wilmington 14.679
Houston 11.304
Singapore 2.490
Fairfield 1.823
Ashburn 1.461
Ann Arbor 1.390
Chandler 1.361
San Jose 1.248
Hong Kong 935
Seattle 775
Beijing 703
Cambridge 630
Rome 626
Dublin 623
Jacksonville 591
New York 491
Medford 448
The Dalles 411
Dearborn 396
Los Angeles 354
Santa Clara 347
Council Bluffs 336
Tokyo 257
Ho Chi Minh City 256
Lawrence 214
Helsinki 206
Hanoi 197
Buffalo 171
Moscow 166
Dallas 162
Milan 156
Munich 149
Orem 146
Lauterbourg 140
San Diego 140
São Paulo 133
Kraków 121
London 101
Nuremberg 101
Menlo Park 96
Zhengzhou 85
North Bergen 83
Chicago 80
Boardman 76
Brussels 75
Chennai 74
Mülheim 72
Redondo Beach 69
Montreal 66
Frankfurt am Main 65
Warsaw 63
Phoenix 60
Stockholm 54
Denver 53
Toronto 52
Jakarta 51
Brooklyn 49
Johannesburg 48
Manchester 48
Amsterdam 47
Rio de Janeiro 45
Palo Alto 44
Guangzhou 43
Atlanta 39
Lappeenranta 39
San Mateo 39
Shanghai 39
Sydney 39
Hangzhou 37
San Francisco 37
Falls Church 36
Norwalk 34
Redwood City 33
Da Nang 32
Brno 31
Engelhard 31
Hefei 31
Colorado Springs 30
Melbourne 30
Mexico City 30
Salt Lake City 30
Vienna 29
Washington 29
Mumbai 28
Verona 28
Ankara 27
Belo Horizonte 27
Haiphong 27
Nanjing 27
Poplar 27
Baghdad 26
Boston 26
Seoul 26
Creede 25
Mountain View 25
Paris 25
Columbus 23
Madrid 22
University Park 22
Totale 63.713
Salva come PNG Salva come JPEG
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 577
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 574
A randomized controlled study for the evaluation of the activity of a triple combination of zidovudine, thymosin-alpha(1) and interferon-alpha in HIV-infected individuals with CD4 counts between 200 and 500 cells/mm(3) 537
Microbiologic characteristics and predictors of mortality in bloodstream infections in intensive care unit patients: A 1-year, large, prospective surveillance study in 5 Italian hospitals 537
Emergence of KPC-producing Klebsiella pneumoniae in Italy 536
Leflunomide-induced DRESS syndrome 528
18-Fluoro-2-deoxyglucose positron emission tomography-computed tomography: an additional tool in the diagnosis of prosthetic valve endocarditis. 519
Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals 513
Human herpesvirus-8 infection in pregnancy and labor: Lack of evidence of vertical transmission 499
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 495
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 485
A relapsing inflammatory syndrome and active human herpesvirus 8 infection 480
A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects. 480
Prognostic factors of long-term CD4+ count-guided interruption of antiretroviral treatment 479
Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy 477
Infection with human herpesvirus type 8 and Kaposi's sarcoma in a central Italian area formerly endemic for malaria 476
Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens 474
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naive to the antiretroviral drugs 474
Novelties in evaluation and monitoring of human immunodeficiency virus-1 infection: Is standard virological suppression enough for measuring antiretroviral treatment success? 474
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 473
Efficient and reproducible new semimicromethod for the detection and titration of HIV in human plasma 464
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (< 400 HIV-RNA cp/ml) during different antiretroviral regimens 463
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing 463
HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI] 462
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 462
Candida Albicans Peritoneal Infection in a patient with slerosing Encapsulating Peritonitis under continous peritoneal dialysis. Efficacy of intra-abdominal Amphotericin B and negative pressure after failure of a systemic therapy 461
Advances in herpesvirus diagnosis 459
Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy. 450
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal 450
Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART 448
Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy 448
Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment 447
Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy 445
Reduction of IFN-gamma and IL-2 production by peripheral lymphocytes of HIV-exposed seronegative subjects 444
Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations 443
A case of rhabdomiolysis associated with raltegravir use 443
High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. 443
Cortical sources of resting state electroencephalographic rhythms probe brain function in naïve HIV individuals 441
High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis 440
ellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy. 437
Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration 436
HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity 435
Human herpesvirus 8 and human herpesvirus 2 infections in prison population 433
A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART. 433
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro 433
Increase in neutralizing antibody titer against sequential autologous HIV-1 isolates after 16 weeks saquinavir (invirase) treatment 429
Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy 429
Five human immunodeficiency virus type 1 phenotypic variants with different MT-2 cell tropisms correlate with prognostic markers of disease 429
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 429
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: impact on susceptibility to first-line strategies including Integrase strand-transfer inhibitors 429
Correlates of HIV, HBV, and HCV infections in a prison inmate population: Results from a multicentre study in Italy 428
Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient. 428
Viral growth assay to evaluate the replicative capacity of HIV-1 isolates 427
Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia 427
Adherence and genotypic drug resistance mutations in HIV-1-infected patients failing current antiretroviral therapy 426
Plasma Viremia Titration and RNA Quantitation in ICD-p24 Negative HIV Type-1-Infected Patients 426
Prevalence of HHV-8 infection in Albanian adults and association with HBV and HCV 424
Complication of nasal piercing by Staphylococcus aureus endocarditis: a case report and a review of literature. 424
Characterization of drug resistance mutations in naive and ART-treated patients infected with HIV-1 in Yaounde, Cameroon 423
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy 421
Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon 420
Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study 419
Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: A cross-sectional evaluation 417
Primary human herpesvirus 8 infection in immunocompetent children. 417
Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapy. 417
Prevalence trend and correlates of HHV-8 infection in HIV-infected patients 414
HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy 412
Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity. 412
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 412
Infection with human herpesvirus type 8 and human T-cell leukaemia virus type 1 among individuals participating in a case-control study in Havana City, Cuba 411
KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection 411
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors 411
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 410
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages 410
HBV, HCV, HDV AND HEV COINFECTIONS IN A COHORT OF HIV POSITIVE PATIENTS IN CAMEROON 409
Non-B HIV type 1 subtypes: Replicative capacity and response to antiretroviral therapy 404
High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians 404
Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. 403
High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatment 402
Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS [1] 402
Erysipeloid cutaneous metastasis from bladder carcinoma 400
HHV-8 infection in African children 400
Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy. 400
Reply to 'Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides', by Barreiro et al. [2] 399
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 399
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia 398
Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy 397
Stavudine protective function and emergence of lamivudine resistance [4] (multiple letters) 397
Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: A systematic review 396
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature 395
Serological testing for human herpesvirus 8 394
Nevirapine use, prolonged antiretroviral therapy and high CD4 nadir values are strongly correlated with undetectable HIV-DNA and -RNA levels and CD4 cell gain. 394
Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. 394
null 393
Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation 393
ISS-NIA Study Group. Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection. 393
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy 393
Infection with human immunodeficiency virus, herpes simplex virus type 2, and human herpes virus 8 in remote villages of southwestern Papua New Guinea 393
Human immunodeficiency virus polymorphisms and zidovudine resistance [3] (multiple letters) 391
Human immunodeficiency virus polymorphisms and zidovudine resistance 389
Totale 43.794
Salva come PNG Salva come JPEG
Categoria #
all - tutte 208.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 208.999
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021508 0 0 0 0 0 0 0 0 0 0 358 150
2021/20222.889 117 226 146 170 124 396 205 145 302 233 172 653
2022/20233.599 324 298 224 517 297 756 271 242 341 31 191 107
2023/20241.713 213 44 167 102 163 343 81 124 39 122 44 271
2024/20257.803 286 1.344 731 642 272 544 767 465 773 766 623 590
2025/202612.645 1.153 598 1.337 1.218 1.219 594 1.835 1.591 1.766 1.217 117 0
Totale 79.529